These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30797271)

  • 1. Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment.
    Soedarsono S; Subiantoro MC
    Indian J Tuberc; 2019 Jan; 66(1):134-138. PubMed ID: 30797271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10.
    Xu L; Cui G; Jia H; Zhu Y; Ding Y; Chen J; Lu C; Ye P; Gao H; Li L; Ma W; Lyu J; Diao H
    J Transl Med; 2016 Jun; 14(1):179. PubMed ID: 27311307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.
    Kang HK; Jeong BH; Lee H; Park HY; Jeon K; Huh HJ; Ki CS; Lee NY; Koh WJ
    Medicine (Baltimore); 2016 Aug; 95(31):e4540. PubMed ID: 27495111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors in patients with AFB smear-positive sputum who receive inappropriate antituberculous treatment.
    Chang CY; Hong JY; Yuan MK; Chang SJ; Lee YM; Chang SC; Hsu LC; Cheng SL
    Drug Des Devel Ther; 2013; 7():53-8. PubMed ID: 23386785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosis.
    Lee HY; Chae KO; Lee CH; Choi SM; Lee J; Park YS; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
    PLoS One; 2014; 9(8):e103768. PubMed ID: 25105410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania.
    Nagu TJ; Spiegelman D; Hertzmark E; Aboud S; Makani J; Matee MI; Fawzi W; Mugusi F
    PLoS One; 2014; 9(3):e91229. PubMed ID: 24642636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring treatment responses in patients with pulmonary TB using serial lung gallium-67 scintigraphy.
    Liu SF; Liu JW; Lin MC; Lee CH; Huang HH; Lai YF
    AJR Am J Roentgenol; 2007 May; 188(5):W403-8. PubMed ID: 17449733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
    Miranda P; Gil-Santana L; Oliveira MG; Mesquita ED; Silva E; Rauwerdink A; Cobelens F; Oliveira MM; Andrade BB; Kritski A
    PLoS One; 2017; 12(4):e0175278. PubMed ID: 28384354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of CA-125 in pulmonary tuberculosis.
    Kim ES; Park KU; Song J; Lim HJ; Cho YJ; Yoon H; Lee J; Lee CT; Park JS
    Tuberculosis (Edinb); 2013 Mar; 93(2):222-6. PubMed ID: 23414674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
    Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
    East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.
    Ritchie SR; Harrison AC; Vaughan RH; Calder L; Morris AJ
    Eur Respir J; 2007 Sep; 30(3):501-7. PubMed ID: 17537768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.
    Azam K; Khosa C; Viegas S; Massango I; Bhatt N; Jani I; Heinrich N; Hoelscher M; Gillespie SH; Rachow A; Sabiiti W
    Front Immunol; 2022; 13():1005692. PubMed ID: 36189292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.